A Phase II trial of bortezomib and dexamethasone in renally-impaired patients with untreated multiple myeloma.
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2016
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Pharmacodynamics
- Acronyms BRIM
- 08 Jun 2016 Status changed from recruiting to completed.
- 23 Jun 2011 New trial record